Masitinib Possible New Treatment of Progressive MS

Masitinib is a first-in-class tyrosine kinase inhibitor targeting the innate immune system. Results from a randomised trial with innovative design features indicated it may present a new treatment option for primary progressive...

Read More
  • 1
  • 2

For latest news and updates
Email-id is invalid